Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Older adults use lifestyle drugs to improve life quality and appearance, but caution is needed due to side effects and potential abuse.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

PSA can help diagnose high androgen levels in women.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.